Topics
-
MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek® (Entrectinib) in Japan
-
Business Results Announcement for the First Three Months of the Fiscal Year Ending March 31, 2023 (See Latest Financial Statements)
-
【Conference presentation】Presenting the Most Recent Data at the Alzheimer's Association International Conference(AAIC) 2022
-
【Publication of a paper】Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy
-
Sysmex Again Selected for Inclusion in All ESG Indices adopted by the GPIF
-
Posted Company Briefing Presentation for Our Stakeholders
Press Releases
- Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2023
-
Pilot, Inc. Becomes Wholly-owned Sysmex Subsidiary Through the Acquisition of Outstanding Shares
- Reinforcing Software Design and Development Capabilities - - Announcement of Personnel Change (PDF：104KB)
-
Sysmex Launches Sample Transportation System Modules for XR™-Series of Automated Hematology Analyzer
- The world’s first automated quality control material measurements contribute to greater automation and efficiency in clinical testing - (PDF：422KB) - Sysmex Files for Manufacturing and Marketing Approval for Genetic Panel Testing System for Inherited Retinal Dystrophy (PDF：235KB)
